aTyr Pharma, Inc. (ATYR)
0.8534
+0.02
(+2.76%)
USD |
NASDAQ |
Apr 17, 16:00
0.856
0.00 (0.00%)
Pre-Market: 20:00
aTyr Pharma SG&A Expense (Quarterly) : 3.905M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Liquidia Corp. | 48.24M |
| Agenus, Inc. | 12.30M |
| Curis, Inc. | 2.883M |
| Plus Therapeutics, Inc. | 4.168M |
| Windtree Therapeutics, Inc. | 1.855M |